Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Myeloid zinc finger 1
(
MZF1
) is a member of the SCAN domain family transcription factors that form dimers through their highly conserved SCAN motifs. Silencing of
MZF1
inhibits cell proliferation, and abnormal expression of
MZF1
results in cancer development. However, a potential role of
MZF1
in metastasis remains unclear. Axl is a receptor tyrosine kinase and was first identified as a transforming gene in
chronic myeloid leukemia
. Axl overexpression induces proliferation, migration, and invasion and is highly expressed in different human cancers. In this study, we show that overexpression of
MZF1
induces migration and invasion in colorectal (Rko, SW480) and cervical (HeLa) cancer cells. In addition, we show that
MZF1
binds to the Axl promoter, transactivates promoter activity, and enhances Axl-mRNA and protein expression in a dose-dependent manner. In vitro, sh-RNA knockdown of Axl reduced
MZF1
-induced migration and invasion in HeLa and Rko cells (P = 0.05). Additionally, Rko cells overexpressing
MZF1
showed increased tumor formation and liver metastasis in the chicken-embryo-metastasis assay in vivo. Furthermore, the expression of
MZF1
and Axl was significantly higher in resected colorectal tumors compared with corresponding normal tissues (P = 0.02; P = 0.05), and
MZF1
expression was positively correlated with Axl gene expression in tumor tissues (P < 0.01). Taken together, this is the first study to show that
MZF1
induces invasion and in vivo metastasis in colorectal and cervical cancer, at least in part by regulating Axl gene expression.
...
PMID:Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer. 2014 42